Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_assertion type Assertion NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_head.
- NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_assertion wasGeneratedBy ECO_0000203 NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.
- NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_assertion wasDerivedFrom befree-2016 NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.
- NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_assertion SIO_000772 25511139 NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.
- NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_assertion evidence source_evidence_literature NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.
- NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_assertion description "[Therefore, in patients with CLL/SLL and rapidly enlarging asymmetric lymphadenopathy and/or extranodal tumors, we strongly advise FCM of fine-needle aspiration biopsy (FNAB) material, including CD62L, CD52, and CD71 analysis as well as assessment of karyotype and at least MYC abnormalities by FISH of the same FNAB material.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.